Which amino-acids do serum and hemofiltrate of critically ill patients with acute renal failure contain?

International Journal of Artificial Organs

Volumn 20, Issue 6, 1997, Pages 309-315

  Guth, H J ^a   Wiersbitzky, M ^a   Ziesche, M ^a   Rose, H J ^a   Kraatz, G ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Acute renal failure; Amino acid metabolism; Continuous hemofiltration

Indexed keywords

AMIDES; BODY FLUIDS; DIAGNOSIS; LACTIC ACID; METABOLISM; NUTRITION; PATIENT TREATMENT; PHYSIOLOGY;

ACUTE RENAL FAILURE; AMIDE GROUPS; AMINO ACID METABOLISM; AMINO-ACIDS; CONTINUOUS HEMOFILTRATION; CRITICALLY-ILL PATIENTS; HEMOFILTRATION; PARENTERAL NUTRITIONS; RENAL FAILURE; RENAL REPLACEMENT THERAPIES;

AMINO ACIDS;

AMINO ACID;

ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; HEMOFILTRATION; HUMAN; METABOLISM; NORMAL HUMAN; SERUM;

EID: 0030856664     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889702000603     Document Type: Article

References (12)

1. Weinberg JM, Davis JA, Abarzua M, Rajan T. Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. J Clin Invest 1987; 80: 1446-54.
2. Garza-Quintero R, Ortega-Lopez J, Stein JH, Venkatachalam MA. Alanine protects rabbit proximal tubules against anoxic injury in vitro. Am J Physiol 1990; 258: 1075-83.
3. Weinberg JM, Davis JA, Abaruza M, Kiani T, Kunkel R. Protection by glycine of proximal tubules from injury due to inhibitors of mitochondrial ATP production. Am J Physiol 1990; 258: 1127-40.
4. Heyman SN, Rosen S. Silva P, et al. Protective action of glycine in cisplatin nephrotoxicity. Kidney Int 1991; 40: 273-9
5. Racusen LC, Finn WF, Whelton A, Solez K. Mechanisms of lysine-induced acute renal failure in rats. Kidney Int 1985; 27: 517-22.
6. Kramer P, Böhier J, Kehr A, et al. Intensive care potential of continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 1982; XXVII: 28-32.
7. Kaplan AA, Longnecker RE, Folkert VW. Continuous arteriovenous hemofiltration. A report of six months' experience. Ann Intern Med 1984; 100: 358-67
8. Paganini EP. Continuous renal replacement therapy in open heart or artificial heart patients with acute renal failure. In: La Greca G, Fabris A, Ronco C, eds. Proceedings of the International Symposium on Continuous arterio-venous Hemofiltration. April 9-11, Vicenza, Italy. Milano: Wichtig Editore 1986; 199-225.
9. Davenport A, Roberts B. Amino-acid losses during continuous high-flux hemofiltration in the critically ill patient. Crit Care Med 1989; 17: 1010-4.
10. Frankenfield DC, Badellino MM, Reynolds N, et al. Amino acid loss and plasma concentration during continuous hemodiafiltration. J Parent Ent Nutr 1993; 17: 551-61.
11. Thompson GN, Butt WW, Shann FA, et al. Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism. J Pediatr 1991; 118: 879-84.
12. Ronco C, Brendolan A, Borin D, et al. Permeability characteristics of polysulfonic membranes in CAVH. In: Sieberth HG, Mann H, eds. Continuous arteriovenous hemofiltration (CAVH). Int Conf on CAVH, Aachen, Germany, Karger Basel: 1985; 59-63.